Cumberland Pharmaceuticals CPIX Sancuso — Non-current inventories
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's sancuso — non-current inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's sancuso — non-current inventories?
- Cumberland Pharmaceuticals (CPIX) reported sancuso — non-current inventories of $615.87K in Q1 2026.
- How has Cumberland Pharmaceuticals's sancuso — non-current inventories changed year-over-year?
- Cumberland Pharmaceuticals's sancuso — non-current inventories increased by 60.0% year-over-year, from $384.91K to $615.87K.
- What does sancuso — non-current inventories mean?
- This metric measures the value of inventory associated with a specific pharmaceutical product that is not expected to be sold or consumed within the standard twelve-month operating cycle. It reflects long-term supply chain commitments, strategic stockpiling, or products with extended shelf lives held to ensure consistent market availability. High levels of non-current inventory may indicate potential obsolescence risks or capital tied up in slow-moving assets, while appropriate levels support long-term supply chain resilience.